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1. Introduction 
Regulation of gene expression in eukaryotes 
appears to be exerted at least partially through selec- 
tive transcription of specific DNA-chromatin 
sequences by endogenous RNA polymerases. As 
previously reported neurochemical studies revealed 
considerably higher RNA synthesis in mature neuronal- 
and astroglial- than in oligodendro- or microglial- 
enriched rat brain nuclear fractions [l-4] . More 
recent studies on the initiation of RNA synthesis 
support the view that chromatin proteins are involved 
in the selection of initiation sites for RNA poly- 
merases [5,6]. Potentially the different rates of phos- 
phorylation [7] and acetylation [8] of chromatin- 
bound neuronal and glial proteins as well as the differ- 
ences in chromatin composition between both nuclear 
fractions [7,9] may be involved in the regulation of 
neuronal and glial transcription. 
It is the main goal of this paper to present new 
insights in the mechanisms controlling the different 
degree of neuronal and glial chromatin-templated 
transcription. The experiments to be described deal 
with the quantitative determination of the number 
of initiation sites in neuronal- and glial-enriched rat 
brain nuclei using isolated rat brain RNA polymerase. 
2. Methods 
2.1. Isolation of nuclei 
Rat brain nuclei were isolated from female albino 
Wistar rats weighing 160-l 80 g and purified by ultra- 
centrifugation through 1.9 M sucrose with 1 mM 
North-Holland Publishing Company - Amsterdam 
MgC12 as described elsewhere [6]. Neuronal- (N) and 
glial- (G)enriched nuclear fractions were separated 
from isolated brain nuclei by discontinuous sucrose 
density gradient centrifugation [lo] . The nuclear 
fractions obtained morphologically corresponded to 
those described previously [7,10] and characterized 
by [ 11 ,I 21. The neuronal nuclei enriched fraction 
obtained as regards its composition is in good accor- 
dance with zone I and the glial nuclei enriched frac- 
tion with zone IV obtained by Austoker et al. [l] 
by means of zonal centrifugation. Since nuclei offer 
the advantage of chromatin in a minimally disturbed 
state [ 131 neuronal- and glial-enriched nuclei were used 
as templates for determination the number of RNA 
initiation sites with the aid of exogenous nuclear 
rat brain RNA polymerase. 
2.2. Preparation of rat brain nuclear RNA polymerase 
Preparation of nuclear brain RNA polymerase was 
exactly the same as described by Jacob et al. [ 141. 
The enzyme preparation was standardized for its 
protein content and used as RNA polymerizing 
enzyme in assays in which the number of RNA initia- 
tion sites were quantitatively determined. 
2.3. Conditions for RNA synthesis 
The ionic composition of the assay mixtures was 
chosen to assure that RNA polymerase A and B 
would both be active during the incubation period and 
contained in a final volume of 50 ~1 the following 
components essentially as described by Reeder and 
Roeder [ 151: 50 mM Na-N-2-hydroxyethylpiperazine- 
N’-Zethanesulfonic acid, pH 7.9; 2 mM MnCl,; 5 mM 
Mg(OAc)z ; 150 mM KCl; 2.5 mM dithiothreitol; 10% 
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glycerol; 1% bovine serum albumin; 1 .O mM each ATP, 2.5. Analytical procedures 
GTP, CTP, 0.4 mM [3H]UTP (spec. act. 0.25 mCi/ DNA was determined by the diphenylamine reac- 
mmol) and 20 ~1 neuronal- or glial-enriched nuclei tion [ 191 and protein by the method of Lowry et al. 
(3-5 pg DNA). WI. 
RNA polymerase B activity was determined by its 
sensitivity to low cu-amanitin concentrations (2.5 /-Lg/ 
ml), the remaining a-amanitin-resistant activity was 
defined as RNA polymerase A activity. RNA poly- 
merase C activity seems to be a minor component of 
the cu-amanitin-resistant activity as revealed by addition 
of 150 pg Lu-amanitin/ml to the assay mix and was 
not measured separately. After equilibration the reac- 
tion was incubated at 25°C for various times. For 
kinetic studies 50 1.11 aliquots were pipetted onto 
Whatman 3 MM paper disks, precipitated in ice-cold 
5% TCA with Na4PZ07 and counted for radioactivity 
as described previously [ 161. 
3. Results and discussion 
2.4. Measurement of RNA initiation sites 
The number of initiation sites on neuronal and 
glial templates was titrated under conditions com- 
pletely eliminating reinitiation using the technique 
described by Cedar and Felsenfeld [ 171 and Tsai 
et al. [S] . Either various concentrations of rat brain 
RNA polymerase preparation (O-l 0 pg protein) were 
incubated with fixed amounts of neuronal- and glial- 
enriched nuclei (10 pg DNA), or a fixed concentration 
of brain RNA polymerase preparation (5 pg protein) 
was incubated with varying amounts of neuronal- or 
glial-enriched nuclei (O-75 pg DNA) for 15 min in 
50 ~1 assays containing: 50 mM Tris-HCl pH 7.9; 
3 mM MnCl,; 1 .O mM each ATP and GTP and 
0.125 mM [3H]UTP (spec. act. 0.8 mCi/mmol) to 
allow formation of stable initiation complexes [5]. 
Then RNA chain elongation was permitted by addi- 
tion of 1 .O mM CTP and MgClz and (NH4)$04 in 
final concentrations of 5 .O respectively 400 mM. 
With increasing enzyme to template respectively 
template to enzyme ratios a saturation of high affinity 
RNA initiation sites is reached [ 181. Under condi- 
tions preventing reinitiation and guaranteeing template 
saturation, the number of RNA chains initiated is 
equal to the number of RNA initiation sites on the 
template used and can be calculated from the satura- 
tion points of the titration curves (fig.2 A-C) [ 181. 
The UMP incorporation into neuronal and glial 
nuclear RNA was determined by the paper disks 
method as described previously [ 161. 
Since incubations conducted at 25°C have proven 
to be more advantageous to that performed at 37°C 
[21] , in vitro RNA synthesis in neuronal- and glial- 
enriched brain nuclei, previously isolated by the 
method described, was performed at 25’C. Conditions 
were chosen so that both RNA polymerase A and B 
activities were measured simultaneously in the same 
assay mix [I 51 and distinguished by their sensitivity 
toward a-amanitin (2.5 pg/ml). Figure I shows a 
typical time course of UMP incorporation into 
neuronal and glial nuclear RNA. In both nuclear 
brain fractions the UMP incorporation displays a 
biphasic time-dependent function with a rapid phase 
during the first 10 min followed by linear incorpora- 
tion up to at least 90 min. 
As verified by investigations using lysed nuclei 
time in minutes 
Fig.1. Kinetics of RNA synthesis of isolated neuronal- and 
glial-enriched rat brain nuclei. Incorporation was conducted 
at 25°C as described under ‘Methods’ with 5 rCi 13H]UTP 
per assay of 50 ~1. At 30 min after the initiation of neuronal 
and glial nuclear RNA synthesis actinomycin D (12.5 fig) and 
an excess of unlabelled UTP were added to the assay mixtures 
(arrows) and the stability of newly synthesized RNA was 
monitored for additional 40 min in both nuclear brain frac- 
tions (. . . . , . . .). Neuronal (0 -------0) and glial (o- 0) 
nuclear RNA synthesis in the absence respectively neuronal 
(*- - - - - - - -0) and glial (o- - - - - - - - -0) RNA synthesis in the 
presence of a-amanitin (2.5 &ml). 
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and increasing amounts of added nucleotide triphos- 
phates (NTPs) the observed differences in UMP 
incorporation into neuronal and glial nuclear RNA are 
independent of endogenous nuclear NTP pool sizes 
and not due to different permeability of neuronal 
and glial nuclear membranes for added NTPs. Further 
differences in the stability of newly synthesized 
neuronal or glial nuclear RNA cannot account for the 
different transcriptional activities of both nuclear 
fractions as revealed by chasing experiments of [3H] 
UMP-labelled neuronal and glial RNA in the presence 
of an excess of unlabelled UTP and actinomycin D 
(12.5 pg/assay) using the technique described pre- 
viously [6] (see fig.1 arrows). 
Since these apparently metabolic differences in 
neuronal and glial RNA synthesis may arise in part 
from differences in the number of initiation sites 
available for RNA polymerases, the total number of 
RNA initiation sites on neuronal and glial nuclear 
templates was quantitatively determined under condi- 
tions completely preventing RNA chain reinitiation. 
The number of high affinity initiation sites was mea- 
sured by titrating either a fixed concentration of 
neuronal- or glial-enriched nuclei with increasing 
amounts of nuclear rat brain RNA polymerase, or by 
titration of a fixed concentration of RNA polymerase 
with varying quantities of neuronal- or glial-enriched 
nuclei. The number of both, high and low affinity 
initiation sites was examined by exposing a fixed 
concentration of neuronal or glial nuclei to a large 
excess of RNA polymerase [23]. Employing slight 
modifications of the technique developed by Cedar 
and Felsenfeld [ 171 and Tsai et al. [5] brain RNA 
polymerase and neuronal- and glial-enriched lysed 
nuclei were incubated under low ionic strength condi- 
tions only in the presence of three nucleotide triphos- 
phates to allow formation of stable initiation com- 
plexes but to prevent excessive RNA chain elongation. 
After the initiation reaction is complete (15 min), non- 
specific initiation and reinitiation were eliminated by 
addition of (NH4)aS04 up to a final concentration of 
0.4 N [22]. Simultaneously the fourth nucleotide 
triphosphate is given to the assay mixture to permit 
RNA chain elongation of the RNA chains initiated 
immediately before for additional 15 min. 
As can be seen from the RNA polymerase satura- 
tion curves (fig.2A) the final UMP incorporation 
obtained at the end of the elongation period increased 
w protein 
Fig.2 (A) RNA polymerase saturation curves on neuronal 
(0 0) and glial (o ---o) nuclear templates. A 
fixed concentration of either neuronal- or glial-enriched nuclei 
(10 pg DNA) was incubated with increasing amounts of rat 
brain RNA polymerase (prepared according to Jacob et al. 
[ 141 and standardized by the protein content of the prepara- 
tion). At the end of 15 min when the initiation reaction was 
complete RNA chain elongation was started by addtion of 
CTP, MgCl and (NH,),SO, at tinal concentrations of 1.0 mM, 
5 mM and 400 mM and the assay mixtures were further 
incubated at 25°C for 15 min. RNA synthesized was precipitat- 
ed and counted as described under ‘Methods’. (B) Net exogenous 
RNA polymerase activity of neuronal (0 0) and glial 
(o o) enriched nuclei was obtained by subtracting 
endogenous RNA synthesis values from the corresponding 
values of endogenous plus exogenous RNA synthesis for 
neuronal_and glial-enriched nuclei. (C) Endogenous 
(o-o-o-o-o-*) and endogenous plus exogenous (0 l l l l 0) 
RNA synthesis of neuronal enriched nuclei and endogenous 
(o-o-o-o-o-o) and endogenous plus exogenous (o o o o o o) 
RNA synthesis of glial enriched nuclei. Assays contained 
increasing amounts of lyzed neuronal- and glial-enriched rat 
brain nuclei either with or without a fixed concentration 
(5 c(g protein) of rat brain nuclear RNA polymerase prepara- 
tion. Incubation conditions were the same as described in 
tig2A. 
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with the increasing amount of RNA polymerase added 
to a fixed concentration of neuronal or glial nuclei 
until the transition points are reached. These points 
of titration corresponded to the amount of RNA poly- 
merase molecules required to saturate the available 
initiation sites on neuronal respectively glial templates. 
In comparison to glial nuclei a greater quantity of 
RNA polymerase was needed to saturate the initiation 
sites present in neuronal nuclei. The amount of RNA 
polymerase needed to reach the titration point for 
neuronal nuclei was twice the amount required to 
saturate the glial initiation sites (fig.ZA) indicating a 
greater number of high affinity RNA polymerase initia- 
tion sites on neuronal template. The validity of these 
results was confirmed by employing an alternative 
assay measuring the number of initiation sites by 
exposing fixed amounts of RNA polymerase to 
increasing amounts of neuronal- or glial-enriched 
nuclei (&.2B-C). 
In addition to the determination of the number of 
high affinity initiation sites, we quantified the total 
number of initiation sites including high and low 
affinity RNA initiation sites on neuronal and glial 
nuclear templates by adding a large excess of brain 
RNA polymerase to a fixed concentration of either 
neuronal- or glial-enriched nuclei. Under this condi- 
tion the UMP incorporation into neuronal and glial 
nuclear RNA is a function solely of the available 
initiation sites present in neuronal and glial nuclei, 
independently of the enzyme concentration applied. 
The total number of initiation sites determined under 
enzyme excess conditions was found to be approxi- 
mately 40% higher in both nuclear brain fractions as 
compared with values obtained by titration of fixed 
amounts of nuclei with increasing concentrations of 
RNA polymerase. Taken together, independently of 
the method applied a higher number of initiation sites 
available for RNA polymerase was determined on 
neuronal as compared to glial nuclear template. 
In conclusion, the results outlined above clearly 
demonstrate a connection between the number of 
RNA initiation sites on the neuronal nuclear template 
and its transcriptional capacity both being higher than 
the corresponding values of the glial nuclear template. 
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